Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday.
The new price for the Pfizer shot was 19.50 euros (USD 23.15) against 15.50 euros previously, the newspaper said, citing portions of the contracts seen.
The price of a Moderna vaccine was USD 25.50 a dose, the contracts show, up from about 19 euros in the first procurement deal but lower than the previously agreed USD 28.50 because the order had grown, the report said, citing one official close to the matter.
- Health Canada approves drug to treat hot flashes for some cancer patients
- Manitoba’s largest hospital still recovering after cyberattack
- Toronto Public Health investigating legionnaires’ disease outbreak near downtown core
- Hamilton ‘black soot’ not expected to pose long-term risk, public health says
The European Commission said on Tuesday that the EU is on course to hit a target of fully vaccinating at least 70% of the adult population by the end of the summer.
Get weekly health news
In May, the EU said it expects to have received more than a billion doses of vaccines by the end of September from four drugmakers.
Pfizer and Moderna were not immediately available for comment to Reuters.
(USD1 = 0.8425 euros)
— Reporting by Sabahatjahan Contractor in Bengaluru
Comments
Want to discuss? Please read our Commenting Policy first.